Similar articles

• Vasodilator therapy for chronic heart failure.

  Chatterjee K, Parmley WW. Chatterjee K, et al. Annu Rev Pharmacol Toxicol. 1980;20:475-512. doi: 10.1146/annurev.pa.20.040180.002355. Annu Rev Pharmacol Toxicol. 1980. PMID: 6770743 Review. No abstract available.
• [Vasodilator therapy of heart failure].

  Mathey D. Mathey D. Dtsch Med Wochenschr. 1979 Apr 20;104(16):563-4. doi: 10.1055/s-0028-1103945. Dtsch Med Wochenschr. 1979. PMID: 108068 German. No abstract available.
• Guidelines for vasodilator therapy of congestive heart failure in infants and children.

  Artman M, Graham TP Jr. Artman M, et al. Am Heart J. 1987 Apr;113(4):994-1005. doi: 10.1016/0002-8703(87)90062-7. Am Heart J. 1987. PMID: 3031972 No abstract available.
• Oral vasodilator therapy for chronic heart failure: a plea for caution.

  Packer M, Meller J. Packer M, et al. Am J Cardiol. 1978 Oct;42(4):686-9. doi: 10.1016/0002-9149(78)90642-2. Am J Cardiol. 1978. PMID: 358821 Review. No abstract available.
• Vasodilators for chronic congestive heart failure.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 1984 Dec 21;26(677):115-6. Med Lett Drugs Ther. 1984. PMID: 6390110 No abstract available.